https://lipocine.com/ https://lipocine.com/lipocine-to-host-virtual-kol-event-on-lpcn-2401-for-improved-body-composition-in-obesity-management-on-october-16-2024/ 2026-03-24T12:01:03+00:00 https://lipocine.com/lipocine-to-present-at-h-c-wainwright-8th-annual-mash-investor-conference/ 2025-09-27T09:53:14+00:00 https://lipocine.com/lipocine-announces-phase-2-data-on-lpcn-2401-to-be-presented-at-obesityweek/ 2025-09-27T09:53:08+00:00 https://lipocine.com/lipocine-announces-positive-oral-brexanolone-quantitative-eeg-results/ 2024-10-25T17:50:25+00:00 https://lipocine.com/lipocine-announces-supply-and-distribution-agreement-with-pharmalink-to-commercialize-tlando-in-the-gulf-cooperation-council-gcc-countries/ 2024-10-25T17:49:57+00:00 https://lipocine.com/lipocine-to-present-at-h-c-wainwright-26th-annual-global-investment-conference/ 2024-10-25T17:47:56+00:00 https://lipocine.com/lipocine-announces-financial-results-for-the-second-quarter-ended-june-30-2024/ 2024-10-25T17:47:24+00:00 https://lipocine.com/lipocine-announces-completion-of-dosing-in-pivotal-study-of-postpartum-depression-candidate-lpcn-1154/ 2024-10-25T17:46:15+00:00 https://lipocine.com/lipocine-announces-lpcn-1154-meets-bioequivalence-with-iv-brexanolone-in-pivotal-study/ 2024-10-25T17:44:35+00:00 https://lipocine.com/lipocine-presents-52-week-results-from-lpcn-1148-phase-2-study-in-late-breaking-session-at-easl-congress-2024/ 2024-10-25T17:44:16+00:00 https://lipocine.com/lipocine-announces-financial-results-for-the-first-quarter-ended-march-31-2024/ 2024-10-25T17:44:02+00:00